LANGHORNE, PA — PANTHERx Rare Pharmacy and Savara Inc. (Nasdaq: SVRA) announced an exclusive U.S. distribution agreement for MOLBREEVI, an investigational inhaled therapy under FDA review for a rare ...

Inflammatory Bowel Disease (IBD) is a chronic disease of inflammation along the digestive tract. There are two forms of IBD, including Crohn’s diseas | Immunology ...

Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc.